Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

Coles is recalling two of its homebrand peanut butter products over concerns they have been contaminated with aflatoxin, a ...

How is Randy Moss feeling after his cancer treatment? Like straight cash, homie. The Hall-of-Fame wide receiver turned football analyst will rejoin ESPN’s Sunday NFL Countdown crew full-time after his ...

Punjab Dr. Usman Anwar has approved the release of over Rs3.575 million in additional funds to support the medical treatment of police personnel and their families. According to the Punjab Police ...

It was determined in Haylee’s case that surgery is currently not an option. Her treatment includes immunotherapy to target the cancer throughout her body, along with Y90 radiation beads being ...

Posted: June 19, 2025 | Last updated: June 19, 2025 ABC News' Dr. Tara Narula breaks down the condition affecting nearly one in four Americans and the promising treatment giving patients new hope.

Gabriel’s mother, Crystal Martinez, is a cancer survivor herself. She says watching her son endure such difficult treatments, with no progress, has been heartbreaking. “The treatments he did were not ...

Comparative study process of LLMs and doctors in predicting immune therapy response for liver cancer. Credit: Wang Tengfei, from the Journal of Medical Systems (2025). DOI: 10.1007/s10916-025-02192-1 ...

The treatment is still prohibitively expensive, with one-time costs for approved cancer therapies approaching $500,000 or more. And researchers don’t yet know how patients will fare in the long run.

Job cuts at the National Institutes of Health have left many cancer patients in limbo as they wait on their specialized treatment to be completed, The Washington Post reported June 18. Here’s ...

A RECENT international Phase 3 clinical trial has demonstrated that a combination of toripalimab and bevacizumab significantly improves survival outcomes in patients with previously untreated advanced ...

The firm will assess irpagratinib plus best supportive care in patients with FGF19-overexpressing advanced liver cancer.